Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$12.16 - $19.42 $1,216 - $1,942
-100 Reduced 20.0%
400 $4,000
Q2 2022

Jul 22, 2022

SELL
$9.99 - $21.35 $59 - $128
-6 Reduced 1.19%
500 $5,000
Q1 2022

May 16, 2022

SELL
$14.08 - $27.63 $7,054 - $13,842
-501 Reduced 49.75%
506 $9,000
Q1 2021

Jun 17, 2021

SELL
$39.71 - $90.58 $3,971 - $9,058
-100 Reduced 9.03%
1,007 $37,000
Q4 2020

May 19, 2021

SELL
$27.07 - $84.35 $5,143 - $16,026
-190 Reduced 14.65%
1,107 $45,000
Q3 2020

Sep 07, 2021

BUY
$28.06 - $37.16 $5,612 - $7,431
200 Added 18.23%
1,297 $38,000
Q2 2020

Sep 07, 2021

BUY
$18.5 - $34.34 $10,915 - $20,260
590 Added 116.37%
1,097 $31,000
Q1 2020

Sep 07, 2021

BUY
$14.88 - $32.78 $7,544 - $16,619
507 New
507 $10,000
Q4 2019

Sep 07, 2021

SELL
$19.49 - $32.63 $9,881 - $16,543
-507 Closed
0 $0
Q1 2019

Sep 07, 2021

SELL
$19.43 - $26.41 $3,886 - $5,282
-200 Reduced 28.29%
507 $12,000
Q4 2018

Sep 07, 2021

SELL
$18.19 - $31.79 $5,329 - $9,314
-293 Reduced 29.3%
707 $14,000
Q3 2018

Sep 07, 2021

SELL
$27.65 - $38.39 $8,986 - $12,476
-325 Reduced 24.53%
1,000 $31,000
Q1 2018

Sep 07, 2021

SELL
$29.84 - $44.08 $5,968 - $8,816
-200 Reduced 13.11%
1,325 $43,000
Q4 2017

Sep 07, 2021

BUY
$21.89 - $31.34 $33,382 - $47,793
1,525
1,525 $46,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $92.1M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.